Insider · CIK 0001033157
Steven J Lubman
Files at SPRS (SURGE COMPONENTS INC). First filing -, latest -.
Steven J Lubman files SEC Form 4 as CFO and director at SPRS (SURGE COMPONENTS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven J Lubman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 22, 2025 | SPRS SURGE COMPONENTS INC | AGrant or award Stock Option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 50,000 | May 27, 2025 |
| Apr 10, 2025 | SPRS SURGE COMPONENTS INC | MOption exercise Common Stock | +50,000 | $1.41 | $71k | 1,070,952 | Apr 14, 2025 |
| Apr 10, 2025 | SPRS SURGE COMPONENTS INC | FTax withholding Common Stock | -21,986 | $2.20 | $48k | 1,048,966 | Apr 14, 2025 |
| Apr 10, 2025 | SPRS SURGE COMPONENTS INC | FTax withholding Stock Optionderivative | -50,000 | $0.00 | $0 | 0 | Apr 14, 2025 |
Questions about Steven J Lubman
Answered from the filings on this page, as of the latest one.
Is Steven J Lubman buying or selling?
Steven J Lubman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven J Lubman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven J Lubman has 0.
Where does Steven J Lubman file Form 4?
Steven J Lubman has filed Form 4 at SPRS (SURGE COMPONENTS INC) as V P, Secretary & Treasurer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.